New Eversense Bridge Program; Senseonics Q4 ’18 Earnings Update
Senseonics hosted its Q4 ’18 earnings call and provided updates to its Eversense clinical and commercial activities. Of note, Senseonics is launching a new bridge program to help drive user adoption. Recall, Senseonics recently renewed its distribution agreement with Roche and hired Fran Kaufman, former Medtronic CMO. Below, FENIX provides highlights and insights from the earnings call including updates to the Senseonics pipeline.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.